Publications by authors named "Stuart Hossack"

Claim this Profile
C
CYP11B2 inhibitor dexfadrostat phosphate suppresses the aldosterone-to-renin ratio, an indicator of sodium retention, in healthy volunteers.
Paolo Mulatero, Michael Groessl, Bruno Vogt, Christoph Schumacher, Ronald Edward Steele, Stuart Hossack

Br J Clin Pharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to Tobacco Heating Products: A Randomized, Controlled Study in Healthy Japanese Subjects.
Nathan Gale, Mike McEwan, Alison C Eldridge, Ian M Fearon, Neil Sherwood, Stuart Hossack

Nicotine Tob Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SELECT-3: a phase I study of selumetinib in combination with platinum-doublet chemotherapy for advanced NSCLC in the first-line setting.
Alastair Greystoke, Nicola Steele, Hendrik-Tobias Arkenau, Fiona Blackhall, Noor Md Haris, Stuart Hossack

Br J Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised, controlled, two-Centre open-label study in healthy Japanese subjects to evaluate the effect on biomarkers of exposure of switching from a conventional cigarette to a tobacco heating product.
Nathan Gale, Mike McEwan, Alison C Eldridge, Neil Sherwood, Edward Bowen, Stuart Hossack

BMC Public Health· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Pharmacokinetics, and Pharmacodynamics Study in Healthy Subjects of Oral NEO6860, a Modality Selective Transient Receptor Potential Vanilloid Subtype 1 Antagonist.
William Brown, Richard L Leff, Andrew Griffin, Stuart Hossack, Roxane Aubray

J Pain· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized clinical trial: pharmacokinetics and safety of multimatrix mesalamine for treatment of pediatric ulcerative colitis.
Carmen Cuffari, David Pierce, Bartosz Korczowski, Krzysztof Fyderek, Heather Van Heusen, Stuart Hossack

Drug Des Devel Ther· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 randomized study evaluating the effect of omeprazole on the pharmacokinetics of a novel 5-hydroxytryptamine receptor 4 agonist, revexepride (SSP-002358), in healthy adults.
David Pierce, Mary Corcoran, Maria Velinova, Stuart Hossack, Mieke Hoppenbrouwers

Drug Des Devel Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of pharmacodynamic equivalence and tolerability of lanthanum carbonate oral powder and tablet formulations: a single-center, randomized, open-label, 2-period crossover study in healthy subjects.
David Pierce, Stuart Hossack, Antoine Robinson, Pinggao Zhang, Patrick Martin

Clin Ther· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol.
David Pierce, Stuart Hossack, Lynne Poole, Antoine Robinson, Heather Van Heusen

Nephrol Dial Transplant· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A solid-state approach to enable early development compounds: selection and animal bioavailability studies of an itraconazole amorphous solid dispersion.
David Engers, Jing Teng, Jonathan Jimenez-Novoa, Philip Gent, Stuart Hossack

J Pharm Sci· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis